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ABSTRACT 
Natural antisense transcripts (NATs) are non-coding RNAs that can regulate the 
expression of their counterpart protein-coding transcript. While NATs are widespread in 
eukaryotic genomes, very little is known about their mechanism. Our study focuses on 
gaining a better understanding of the function of NATs in Toxoplasma gondii, a pathogenic 
unicellular eukaryote. We recently characterized the gene encoding the first committed 
enzyme in SUMOylation, named Ubiquitin-like protease 1 (TgUlp1), and showed that the 
expression of TgUlp1 is vital to the life cycle of T. gondii. Interestingly, the locus of 
TgUlp1 also transcribes a NAT species. Using a dual luciferase assay and RT-qPCR, we 
identified the promoters of TgUlp1 mRNA and NAT and measured their transcript levels 
in tachyzoites and bradyzoites. We found that TgUlp1 mRNA and NAT are differentially 
regulated at the transcriptional level via promoter activity and transcript turnover. 
Furthermore, the products of TgUlp1 NAT processed by RNase III retain the ability to 
lower the expression of reporters carrying TgUlp1 mRNA sequences, suggesting the 
involvement of RNA interference pathway. In Dicer-knockout (TgDicer-KO) and 
Argonaute-knockout (TgAgo-KO) transgenic strains, a higher level of TgUlp1 NAT, and 
much lower level of TgUlp1 mRNA was detected, suggesting that Dicer and Ago may be 
involved in maintaining TgUlp1 mRNA. Although we were unable to determine the direct 
effect of TgUlp1 NAT on mRNA, we showed that the introduction of TgUlp1 NAT by 
electroporation negatively affected the level of TgUlp1 mRNA. Consequently, regulation 
by TgUlp1 NAT would also affect TgUlp1 protein levels and ultimately the SUMOylation 
pathway in T. gondii which plays an important role in host cell invasion and cyst genesis. 
However, underlying mechanisms remain to be investigated.    
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CHAPTER 1 – LITERATURE REVIEW 
1.1 Noncoding RNA 
Whole transcriptome analysis has revealed that up to 90% of eukaryotic genomes 
are transcribed [1]. However, only 1–2% of the transcripts are protein coding. Majority of 
the remaining ~98% of transcripts are functional non-protein-coding RNA (ncRNA) 
molecules. ncRNAs play an important role in cellular processes, including gene imprinting, 
differentiation and development, antiviral response, apoptosis, cell cycle control and more 
[2, 3].  
1.2 Classification of ncRNA  
ncRNA can be classified by their length. An arbitrary 200-nucleotide threshold is 
used to separate short and long ncRNA. To date, the best studied short ncRNA are 
microRNA (miRNA) and small interference RNA (siRNA), which regulate gene 
expression through the RNA interference (RNAi) pathway. Long ncRNAs (lncRNAs) are 
larger than 200 nts and can be over 100,000 nts in length. LncRNAs make up the largest 
portion of ncRNA and are highly diverse in structure and function [3].  LncRNAs are 
detected in the genomes of animals, plants, yeast, prokaryotes and even viruses. However, 
they are poorly conserved when compared to well-studied short ncRNAs like miRNAs or 
siRNAs [4].  
LncRNAs are further classified based on their origin within the genome, including 
their location and orientation (Figure 1.1). Intergenic lncRNA are transcribed from the 
location between two genes, regardless of their orientation. Intronic lncRNAs are 
transcribed entirely from introns of protein-coding genes. Sense lncRNAs are transcribed 
from the sense strand of protein-coding genes and overlap the exons. Antisense ncRNAs 
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are transcribed from the antisense strand of protein-coding genes, and also referred to as 
natural antisense transcripts (NAT). 
 
 
Figure 1.1  Classification of Noncoding RNAs by Their Origin  
ncRNAs can be classified into four types according to their position in the genome. Green 
bars/arrows represent the transcription region and direction of sense transcript and the red 
bars/arrows represent the transcription region and direction of the ncRNA. Modified from 
[3]. 
(A) Intergenic ncRNAs are transcribed from the genomic sequences located between two 
genes, regardless of their orientation.  
(B) Intronic ncRNAs are derived entirely from the introns of protein encoding genes.  
(C) Sense lncRNAs are transcribed from the sense strand of protein-coding genes and 
overlap with exons of the gene.  
(D) Antisense lncRNAs are transcribed from the antisense strand of protein-coding genes.   
(A) Intergenic 
  
(B) Intronic 
(D) Antisense 
Gene 5’ 
3’ 
3’ 
5’ ncRNA 
(C) Sense  
  ncRNA Exon 1 Exon 2 
ncRNA Exon 1 Exon 2 
ncRNA Gene 1 Gene 2 
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1.3 Natural Antisense Transcripts 
NATs are widespread in eukaryotes and are recognized as important regulators of 
gene expression. Up to 72% of transcriptional units in mice and 22 - 40% in human 
(depending on cell type) are transcribed in both orientations, and comparable numbers have 
been suggested for other eukaryotes [5, 6]. Similar to mRNA, NATs are capped, poly-
adenylated, and spliced [3]. Their transcription is also controlled by promoters and 
enhancers and transcribed by RNA polymerase II. Unlike mRNAs, NATs preferentially 
accumulate in the nucleus, in addition to other cellular compartments, such as mitochondria 
[7]. NAT can be broadly grouped into two categories based on the location of their target 
as cis- and trans-NATs. 
1.4 Cis-NATs 
Cis- NATs have been extensively studied in many eukaryotes and found to play a 
variety of regulatory roles. They are transcribed from the same genomic locus as their target 
but from the opposite DNA strand. Therefore, cis-NATs have perfect base-pairing to their 
target transcript. This RNA-RNA interaction can result in translational inhibition, mRNA 
degradation, or promote RNA stability [8].  
There are three types of cis-NATs based on their position relative to the position of 
their target gene (Figure 1.2). In head-to-head orientation, the sense and antisense 
transcripts overlap on their 5’-end. In addition, the 5’-UTR of the sense gene may harbour 
a bidirectional promoter capable of initiating transcription for both sense and antisense 
transcripts. Tail-to-tail describes transcripts overlapping at the 3’-ends. In full overlap, 
NAT completely overlaps with the sense transcript. The transcription starts site (TSS) of 
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NAT occurs within the sense gene, resulting in high level of complementarity between the 
sense and antisense transcript.  
 
 
 
 
 
Figure 1.2  Classification of Cis-NATs Based on Their Orientation Relative to 
Their Target Gene 
Cis-NATs can be classified into three types according to their positions relative to the sense 
counterpart. Green bars represent the transcription region of the sense transcript, and the 
red bars represent the transcription region of the antisense transcript. Arrows represent 
transcription start site (TSS) and direction of transcription. Modified from [3].  
(A) Head-to-head: the sense and antisense transcripts overlap on their 5’-ends.  
(B) Tail-to-tail: sense and antisense transcripts overlap on their 3’-ends.  
(C) In a full overlap (or embedded overlap), the NAT transcription region is totally 
included within the sense transcription region.  
  
(A) Head-to-head 
 
(B) Tail-to-tail 
(C) Full (embedded) overlap 
5’ 
3’ 
5’ 
3’ 
5’ 
3’ 
3’ 
5’ 
3’ 
5’ 
3’ 
5’ 
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1.5 Regulatory functions of Cis-NATs  
Cis-NATs exert their activity through various mechanism including transcription 
interference, chromatin modification, RNA editing, and RNA masking. 
1.5.1 Transcriptional Interference 
Transcriptional interference refers to the suppression of one transcriptional process 
by the direct influence of a second transcriptional process. The close proximity of the cis-
NAT transcriptional unit to the target transcriptional unit makes it possible for gene 
regulation to occur without the direct pairing of the RNA molecules themselves. Four 
mechanisms of transcriptional interference that affect sense and antisense gene pairs have 
been hypothesized (Figure 1.3) [9].   
 (i) Promoter Competition: A sense and antisense gene pair in a head-to-head 
orientation will share a bidirectional promoter that initiates transcription in both 
orientations. During the initiation phase, steric hinderance and competition for the binding 
of RNA Polymerase II (RNAP) and other transcriptional elements can occur for 
bidirectional promoter. This restricts the RNAP binding to one promoter, enhancing its’ 
activity and leads to the downregulation of the other transcript. Over 7000 sense and 
antisense transcript pairs were identified in the human genome and found that 76% exhibit 
a head-to-head formation, sharing a bidirectional promoter, and within this 58% of NATs 
begin from a 500 bps region upstream of the TSS of the sense gene [10].  
(ii) Sitting Duck Mechanism: An RNAP complex that is too slow to transition form 
open to an elongation complex is considered a ‘sitting duck’, which can be dislodged by 
an elongating RNAP from a different promoter downstream.  
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(iii) Occlusion: Occlusion occurs when an elongating RNAP is passing through a 
promoter, therefore blocking the binding of another RNAP. However, transcription 
elongation occurs rapidly in most organisms, meaning that occlusion is very brief, so even 
extremely strong interfering promoters will not produce much occlusion by elongating 
RNAP [11].  
 (iv) RNAP Collision: When both sense and antisense transcription has already 
initiated, the collision of both RNAP complexes during elongation phase can lead to the 
premature termination of one of the complexes. As elongating RNAP envelops both strands 
of DNA, it is likely that both RNAP cannot continue transcription past one another. RNAP 
collisions have been imaged by atomic force microscopy, showing that one elongating 
RNAP forces the opposing RNAP to stall and backtrack [11].  
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Figure 1.3 Mechanisms of Transcriptional Interference 
Promoters of sense genes are represented as green boxes (pSen), and promoters of antisense 
genes are represented red boxes (pAS). Green and red arrows represent direction of 
transcription for sense and antisense transcription respectively. Rounded triangles 
represent RNA Polymerase II (RNAP). Modified from [9]. 
(A) Promoter Competition: In the initiation phase, promoters of head-to-head NATs 
compete for the RNAP and regulatory elements.  
(B) Sitting Duck Mechanism: RNAP that is too slow to start is dislodged by an elongating 
RNAP.  
(C) Occlusion: Elongating RNAP is passing through a promoter, therefore blocking the 
binding of another RNAP.  
(D) RNAP Collision: In the elongation phase, collision between RNAP can lead to a 
transcriptional interference.  
  
(A) Promoter Competition  
(B) Sitting Duck Interference  
(C) Occlusion  
(D) RNAP Collision  
 pAS pSen 
  RNAP 
 pAS pSen   
pAS pSen   
  
  
pAS pSen     
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1.5.2 Chromatin Modification  
Cis-NATs can regulate gene expression through epigenetic mechanisms. A classic 
example is X chromosome inactivation by X-inactive specific transcript (XIST). XIST is 
expressed from a region of chromosome X called the X inactivation center (XIC). XIST 
transcriptionally silences one of the pairs of X chromosomes in early developmental 
process in mammalian females to provide dosage equivalence between males and females. 
XIC also expresses a cis-NAT called Tsix, which silences XIST by directing modification 
of the chromatin structure [12].  
Cis-NATs also influence DNA methylation. DNA methylation is a fundamental 
epigenetic mechanism that regulates gene transcription. It involves the addition (or 
removal) of methyl group to cytosines that are typically found in CpG-rich regions of 
genome, referred to as CpG islands. CpG islands are often found at promoters and first 
exons regions [13]. At unmethylated CpG islands, transcription of the gene is possible; at 
methylated CpG islands the transcription of the gene is blocked. Cis-NATs have been 
implicated in both methylation and demethylation of DNA to regulate gene expression. For 
example, the cis-NAT of Hemoglobin, alpha 2 (HBA2) mediates methylation CpG island 
in the promoter for HBA2, resulting in in gene silencing [14]. Conversely, NAT can also 
be responsible for DNA demethylation to increase transcription. An example is the NAT 
for the tumor suppressor TCF21, which facilitates demethylation of the TCF21 promoter, 
leading to its expression [15]. 
1.5.3 RNA Editing  
RNA editing is an enzymatic reaction catalyzed by adenosine deaminases that act 
on RNA (ADARs) that converts adenosines (A) into inosines (I). ADARs target dsRNA 
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such as those formed by sense and antisense transcripts [16]. After A-to-I editing, inosine 
is interpreted as guanine during splicing or translation. Such modification may control the 
localization or the stability of the edited transcripts. For example, the pre-mRNA of 
PRUNE2 and its overlapping NAT named PCA3, creates a dsRNA that forms a complex 
with ADAR proteins. This leads to A-to-I editing of PRUNE2 transcript, resulting in 
protein downregulation and increase in tumor cell growth [17].  
1.5.4 RNA Masking  
RNA masking refers to the formation of a sense and antisense dsRNA which 
provides protection against post-transcriptional regulation factors that target the gene. This 
provides physical protection by interfering with splicing and translation machineries. For 
example, the expression of the transcription repressor Zeb2 is dependent on RNA masking 
done by its NAT. When the 5′-UTR of Zeb2 mRNA is spliced, it disrupts the sequence for 
the internal ribosome entry site (IRES) required for translation. Therefore, Zeb2 mRNA is 
no longer able to bind ribosomes and translate the protein. When the Zeb2 NAT sequence 
overlaps the 5’-UTR, it prevents the binding of the spliceosome to the 5′ splice site. 
Consequently, the IRES is conserved and Zeb2 protein is translated [18]. 
Conversely, sense and antisense transcript binding may also lead to degradation of 
a transcript, such as in the case of MALAT1, a nuclear-retained long noncoding RNA that 
promotes malignancy. The NAT of MALAT1, named TALAM1, binds the 3’-UTR of 
MALAT1 and allows for cleavage by RNase P. This leads to 3’-end processing and 
maturation that is essential for MALAT1 stability and function [19]. RNA masking also 
prevents miRNA and siRNA from binding as well as protect transcripts from RNAses 
which target single stranded RNA [20, 21].  
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1.6 Trans-NATs  
Trans-NATs are transcribed from a different location than their targets and could 
have complementarity to multiple transcripts with mismatches. Although there are very 
few studies on long trans-NATs, in silico analysis have identified trans-NATs in 
abundance in many eukaryotes such as humans, mice, plants, zebrafish, flies, and worms 
[22].  
There is various evidence to suggests that trans-NATs perform diverse regulatory 
functions. For example, the 2.2-kb NAT transcribed from the HOXC gene cluster on 
chromosome 12, called HOX antisense intergenic RNA (HOTAIR) is capable of 
modifying histones to regulate gene expression. HOTAIR directly interacts with Polycomb 
Repressive Complex 2 (PRC2) with its 5’-end to induce tri-methylation on histone H3, 
lysine 27 and interacts with lysine-specific histone demethylase 1A (LSD1) on its 3’-end 
to induce demethylation on histone H3, lysine 4. These combined modifications, performed 
in trans on chromosome 2, leads to a repressive chromatin structure, thus silencing of 
multiple genes [23]. Long trans-NATs have also been implicated in mRNA degradation 
and translational repression [24]. 
1.7 ncRNA and RNA Interference 
RNA interference is a biological process specific to eukaryotes, in which short 
ncRNA (~22 nts) called siRNA and miRNA inhibit gene expression. Formation of 
si/miRNA requires dsRNA precursors to be cleaved by Dicer, an RNase III enzyme. 
Studies have shown that NAT can serve as a dsRNA precursor needed for si/miRNA 
formation [25, 26]. dsRNA created by internal hairpins loops in NATs can be digested by 
Dicer to form NAT-miRNA. NAT can form long dsRNA with its sense transcript which is 
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digested by Dicer to produce NAT-siRNA. After digestion by Dicer, NAT-si/miRNA is 
bound to Argonaute (Ago) and integrated into the RNA-induced silencing complex (RISC). 
NAT-si/miRNA guides Ago to target mRNA molecules for silencing or degradation based 
on complementary sequence [27]. NAT-siRNA forms perfect base pairs with their target 
mRNA and can act in cis to downregulate the sense gene expression [28]. On the other 
hand, NAT-miRNA forms imperfect base pairs with target mRNA, allowing it to act in 
trans to regulate multiple genes.  
1.8 NATs in Apicomplexa  
Majority of the studies on NATs have been focused in humans; very little is known 
about NATs in Apicomplexa, a phylum of eukaryotic unicellular organisms that consist of 
numerous pathogenic parasites of human and domestic animals. Plasmodium falciparum, 
which causes malaria, is responsible for millions of deaths each year in the developing 
world. Eimeria spp. and Cryptosporidium spp. are important enteric pathogens in humans 
while Neospora spp. and Theileria spp. are veterinary pathogens. Toxoplasma gondii and 
Cryptosporidium parvum have caused water-borne disease outbreaks [29]. 
In Plasmodium, NATs are very frequent and associated with ~24% of all open reading 
frames [30]. A high frequency of antisense RNAs was also observed in T. gondii [31]. 
Radke et al., [31] used serial analysis of gene expression (SAGE) to examine the T. 
gondii transcriptome and reported ~21% of antisense transcription. Both Plasmodium and 
T. gondii also show an inverse relationship between the frequency of antisense transcripts 
and the level of sense transcription [31]. To date, there is no information regarding NAT 
regulation, function, or its implications in cell biology in T. gondii. 
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1.9 Toxoplasma gondii, the Model Apicomplexan 
In contrast to bacterial pathogens, apicomplexan parasites are eukaryotic and share 
many metabolic pathways with their hosts. This makes therapeutic target development 
extremely difficult – a drug that harms an apicomplexan parasite is also likely to harm its 
host. Research on these parasites is challenging because it is difficult to maintain live 
parasite cultures in the laboratory and to genetically manipulate these organisms. However, 
T. gondii is both easily cultured in the lab and readily amenable to genetic manipulation. 
This allows researchers to study many biological or biochemical functions of proteins in 
T. gondii that cannot be done in other apicomplexans. Studies are readily performed in T. 
gondii due to the high efficiency of transient and stable transfection and the availability of 
many cell markers. While results in T. gondii might not always be applicable to other 
Apicomplexa due to differences between the parasites, T. gondii remains an important 
model system for understanding the biology of apicomplexan parasites [32]  
1.10 Discovery of Toxoplasma gondii 
 In 1908, Nicolle and Manceaux were studying the tissue of the rodent 
Ctenodactylus gundi and found a parasite they believed to be Leishmania. However, they 
realized they had discovered a new parasite species and named it Toxoplasma gondii due 
to its crescent morphology; toxo meaning “bow” and plasma meaning “creature” [33]. T. 
gondii is an obligate protozoan parasite belonging to the phylum Apicomplexa. Most 
apicomplexans are characterized by a unique organelle called an apicomplast, which 
perform essential metabolic functions for the viability of the parasites [34]. They also have 
complex life cycles alternating between sexual and asexual cycles in different hosts.  
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T. gondii can infect any nucleated mammalian or avian cell, including humans, 
causing toxoplasmosis. An estimated 15 to 85% of the world adult human population is 
chronically infected with T. gondii, depending on geographical location [35]. In infected 
individuals with healthy immune systems, T. gondii infection is asymptomatic. In 
immunocompromised individuals, the infection can result in serious illness and death.  
1.10.1 Life cycle of T. gondii 
 T. gondii goes through a sexual cycle within definitive hosts and an asexual cycle 
within intermediate hosts. The parasite exists in three forms: sporozoites, tachyzoites, and 
bradyzoites. Oocysts – containing sporozoites – are only produced by sexual reproduction 
in the definitive host, felines, and passed in feces which are then ingested by intermediate 
hosts such as humans (Figure 1.4). The asexual cycle continues in the intermediate host.  
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Figure 1.4 Life Cycle of Toxoplasma gondii in Definitive and Intermediate Hosts   
T. gondii undergoes a sexual cycle in the definitive host to produces oocysts that are 
excreted through feces into the environment. Oocysts are ingested by intermediate hosts 
where the parasite undergoes asexual cycle. Initial infection by tachyzoites is acute. Once 
the host organism triggers an inflammatory response, tachyzoites are forced to convert to 
bradyzoites to become latent. When the host organism becomes immunocompromised, 
bradyzoites convert back to tachyzoites to cause recurrent infection. Modified from [32].  
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1.10.2 Asexual Life Cycle  
 Nicolle and Manceaux found T. gondii in its tachyzoite forms, also known as its 
proliferative form. Tachyzoites infect and grow through a process called the lytic cycle 
(Figure 1.5). First, T. gondii infects a host cell by attaching to and penetrating the cell 
membrane using gliding motility. Once inside the host cell, the parasite is enclosed in the 
parasitophorous vacuole (PV) in the host cell cytoplasm. The PV is derived from the host 
cell membrane as well as lipids and proteins from the parasite [36]. Inside the PV, the 
parasite divides asexually every 6-9 hours through a process called endodyogeny in which 
two daughter cells are produced within the mother cell, which is then consumed by the 
offspring prior to their separation [37]. The host cell ruptures when it can no longer support 
the growth of tachyzoites, and parasites move on to infect the next available cell. 
 Destruction of host cells by tachyzoites growth triggers the host’s immune 
response. In response to this environmental stress, tachyzoites convert to bradyzoites, also 
known as the slowly dividing form of the parasite. Bradyzoites are enclosed in tissue cysts 
that have a glycosylated cyst wall, made up of host and parasite materials that protects the 
parasite from the host immune system. Tissue cysts are most prevalent in neural and 
muscular tissues, including the brain, eyes, and skeletal and cardiac muscles [37]. Tissue 
cysts can persist for the life of the host without triggering an immune response, causing 
chronic infection. If the host organism becomes immunocompromised, the bradyzoites can 
differentiate back into the tachyzoite form and can cause damage in the host [37].  
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Figure 1.5 T. gondii Asexual Life Cycle Within A Host Cell   
Asexual cycle in intermediate host cells results in proliferation of T. gondii through the 
lytic cycle to produce tachyzoites. Tachyzoites attach and penetrate through the cell 
membrane. In the cytoplasm, the tachyzoite is enclosed in a parasitophorous vacuole where 
it replicates intracellularly by endodyogeny.  The host cell ruptures when it can no longer 
support the growth of tachyzoites within it and parasites move on to infect the next 
available cell, completing the lytic cycle. Stress can force tachyzoite into bradyzoites, 
which are enclosed in a tissue cyst. Bradyzoites continue to replicate by endodyogeny but 
much slower. When the host organism becomes immunocompromised, bradyzoites convert 
back to tachyzoites. Modified from [38]. .   
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1.10.3 Toxoplasmosis and Treatment 
Toxoplasmosis can be acquired congenitally and by ingesting infected meat or 
water contaminated with oocysts, which are shed in the feces of infected cats. Acute 
toxoplasmosis, caused by tachyzoites in the lytic phase, can manifest with flu-like 
symptoms including swollen lymph nodes, headaches, fever, fatigue, or muscle aches [39]. 
Immunocompetent individuals can suppress the acute infection and become latent 
(asymptomatic). However, once individuals become immunocompromised, they are at risk 
of recurrent toxoplasmosis which can cause serious illness. This includes damage to the 
central nervous system causing speech abnormalities, motor deficits, seizures, psychosis, 
and is potentially fatal if left untreated [40]. 
Toxoplasmosis is usually asymptomatic; thus, treatment of the infection is limited 
only to individuals showing signs of acute infection, newly infected pregnant mothers, or 
preventative treatment for individuals at high risk of recurrent toxoplasmosis [40]. 
Standard treatment for toxoplasmosis includes a combination of sulfadiazine and 
pyrimethamine [40]. Despite their effectiveness, these drugs can only target tachyzoites 
and have no effect on the remaining tissue cysts. They also have serious side effects; 
pyrimethamine is associated with bone marrow toxicity and sulphadiazine with allergy, 
making these drugs unsuitable for long term treatment [33]. 
1.10.4 T. gondii Clonal Lineages 
Three clonal lineages of T. gondii have been identified; type I, type II and type III 
[41]. Genomic analysis indicates the clonal lineages differ by only 1–2% at the nucleotide 
level. All three strains can infect their intermediate host orally, bypassing the need for the 
sexual stage of the parasitic life cycle which limits genetic recombination and the formation 
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of a wider range of genotypes. Furthermore, infection in intermediate hosts by multiple 
strains is rare, therefore recombinant genotypes are unlikely to emerge [42].  
 Although there is no significant difference at the genomic level, studies in mice 
have shown differences in pathogenesis among the different clonal lineages. Type I strain 
is highly virulent in comparison to type II and III strains [43]. However, studies in North 
America and Europe has identified type II strains as the most prevalent cause of human 
toxoplasmosis in congenital and AIDS patients, while type III is largely confined to 
animals [44].  
1.11 Post-Translational Regulation by SUMOylation 
SUMOylation refers to the reversible addition of a small protein named small 
ubiquitin-like modifier (SUMO) to a protein substrate. SUMO has significant homology 
to ubiquitin, a highly conserved modifier protein found in all eukaryotic cells. SUMO and 
ubiquitin share a similar three-dimensional structure, yet less than 20% amino acid 
sequence similarity [45]. They also share a very similar pathway in conjugating to their 
protein substrates. However, while ubiquitinated proteins are generally targeted for 
degradation, SUMOylated proteins are regulated for different functions within a cell. 
Studies suggest that SUMOylation is involved in many aspects of cell function such as 
DNA damage repair, maintenance of genome integrity, transcription regulation, and 
nuclear transport [46]. The SUMO protein is translated as a precursor peptide, around 100 
amino acids. It has been evolutionary conserved exclusively in eukaryotes. In higher 
eukaryotes such as mammals and plants, there can be up to as many as eight SUMO 
isoforms [47].  
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SUMOylation is initiated by the C-terminal cleavage of extra amino acids in the 
precursor SUMO peptide by a protease named Ubiquitin-like protease 1 (Ulp1) (Figure 
1.6A). Ulp1 is a cysteine peptidase that is highly specific for the SUMO peptide, as it 
recognizes the tertiary structure of SUMO rather than an amino acid sequence [48]. 
Cleavage of the SUMO precursor reveals a di-glycine motif that will ultimately be linked 
to lysine side chains in target protein substrate. After cleavage, the SUMO protein is 
activated by the E1 activating enzyme. This involves the formation of adenylated SUMO 
at the C-terminal carboxyl group of SUMO (Figure 1.6B). The SUMO-AMP bond breaks 
and is followed by the formation of a thioester bond between C-terminal carboxyl group of 
SUMO and cysteine residue in E1 activating enzyme (Figure 1.6C) [49]. Next, SUMO is 
transferred to E2 conjugating enzyme which binds the target protein. SUMO is then 
conjugated to the target protein by E3 ligase enzyme that recognizes the ψKxD/E consensus 
sequence (where ψ is a large hydrophobic residue and x is any residue) [50]. The carboxyl 
group of the di-glycine motif is ligated to the ψ–amino group of a lysine residue on the 
substrate (Figure 1.6D). Ulp1 is also responsible for the removal of SUMO from 
SUMOylated proteins (Figure 1.6E) [48].  
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Figure 1.6 The SUMOylation pathway  
The SUMOylation pathway is initiated by the cleavage of a SUMO precursor at the C-
terminal end to reveal a diglycine motif by Ulp1 (A). The mature SUMO is transferred to 
an E1 then E2 complex (B, C). E3 ligates SUMO to a protein substrate (D), which 
recognizes the ψKxD/E consensus sequence (where ψ is a large hydrophobic residue and 
x is any residue). Ulp1 also removes SUMO from conjugated protein substrates (E). 
Modified from [51].  
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1.11.1 SUMOylation in T. gondii 
Only one gene is encoded for SUMO in lower eukaryotes, including T. gondii and 
other Apicomplexans [52]. Braun et el., [52] characterized the SUMOylation pathway in 
T. gondii. They determined that the TgSUMO knockout or overexpression by a strong 
promoter was determined to be lethal. They identified 120 putative SUMOylated proteins. 
This revealed SUMOylation to be involved in many diverse cellular processes such as 
metabolism, protein translation and folding, signalling, transport and more. After 
developing an antibody against recombinant TgSUMO, they used it to localize free SUMO 
and SUMOylated proteins in the parasite. They observed that TgSUMO was present at the 
tachyzoite membrane at the point of contact during invasion. Once successfully invaded, 
TgSUMO was localized to the parasite nucleus. In bradyzoites, they observed TgSUMO at 
the PV membrane that encapsulates the parasite within the host cell. All of this is indicative 
of the important role that SUMOylation plays during host cell invasion and survival of the 
parasite.  
1.11.2 Ubiquitin-like protease 1 in T. gondii 
Crater et al., [53] characterized the T. gondii homolog of ubiquitin-like protease 
and named it TgUlp1. They found that TgUlp1 is negatively regulated by Tg-miR60, an 
abundant miRNA species in T. gondii type I strain. Misregulation of TgUlp1 is detrimental 
to the parasite, indicating its essential role in the parasite’s life cycle. Surprisingly, they 
also discovered a NAT transcribed from the same locus and referred to it as TgUlp1 NAT. 
TgUlp1 NAT was detected by RT-PCR to be transcribed from the intron 6/7 region of 
TgUlp1 (Figure 1.7). Due to the complementary sequence between TgUlp1 mRNA and 
NAT, it was hypothesized that the expression of TgUlp1 mRNA is self-regulated by 
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TgUlp1 NAT. This would be the first example of a self-regulating gene identified in T. 
gondii.  
1.12 Research Hypotheses and Objectives 
The objective of my study is to gain a better understanding of the mechanism 
controlling the expression of NAT, using T. gondii as a model organism. I aim to identify 
the elements controlling the expression of TgUlp1 NAT and elucidate its mechanism of 
function. The specific aims are as follows: 
(I)  To identify the promoter controlling the expression of TgUlp1 mRNA and 
NAT, I will use a dual luciferase assay. It is hypothesized that the promoter for TgUlp1 
mRNA would lie upstream from exon 1 on the sense strand, and the TgUlp1 NAT would 
lie upstream from intron 7 on the antisense strand (Figure 1.7). If putative promoter 
sequences are capable of initiating transcription, it will successfully drive the expression 
of RnLuc reporter protein which can be quantified.  
 
Figure 1.7 TgUlp1 Locus 
TgUlp1 has 13 exons indicated as black boxes and 12 introns indicated as numbered white 
boxes. Dotted areas are the presumed 5’- and 3’-regions flanking TgUlp1 CDS.  Green 
arrow represents mRNA transcription direction and TSS. Red arrow represents NAT 
transcription direction and TSS. Green and red dotted lines indicate the location of putative 
promoters for mRNA and NAT, respectively.   
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(II) To characterize the expression pattern of TgUlp1 mRNA and NAT between 
tachyzoites and bradyzoites, I will perform RT-qPCR. Many studies have documented 
genes that are differentially expressed in either tachyzoites or bradyzoites, suggesting that 
differential gene regulation plays a major role in coordinating stage conversion in T. gondii. 
My study will provide more insight into the role of NATs in gene expression and stage 
conversion in T. gondii.  
 (III) To determine the regulatory role of TgUlp1 NAT, I will use a dual luciferase 
assay. TgUlp1 mRNA has eleven predicted Tg-mir60 family binding sites [53]. When three 
sites were tested with mir60a – a member of Tg-mir60 family – only one of these sites were 
downregulated, and the other two were unaffected. These sites might be downregulated by 
other members of mir60, such as those derived from TgUlp1 NAT. TgUlp1 NAT 
transcription region overlaps from intron 6 to intron 7, making it possible to form dsRNA 
with the mRNA. TgUlp1 NAT secondary structure also contains many hairpin structures. 
Thus, it is hypothesized that both these dsRNA and hairpin structures could serve as 
precursors of siRNA and miRNA for RNAi.  
 (IV) To investigate the involvement of key enzymes, Dicer and Ago, of  RNAi 
in the expression of TgU1p1 transcripts, RT-qPCR will be performed in Dicer knockout 
(TgDicer-KO) and Ago knockout (TgAgo-KO) strains. The RNase III activity of Dicer and 
ribonuclease activity of Ago will be required for the processing and function of TgUlp1 
NAT. Therefore, changes in TgUlp1 mRNA expression in the transgenic strains will 
implicate RNAi in the function of TgUlp1 NAT.   
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CHAPTER 2 – MATERIALS AND METHODS 
2.1 Cell and Parasite Culture 
2.1.1 Mammalian cell culture 
Human foreskin fibroblasts (HFF, ATCC-1041) grown and maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine 
(Invitrogen, #12100046) supplemented with 10% cosmic calf serum (ThermoFisher 
Scientific, Hylcone, # SH30087.03), and 5 μg/ml antibiotic-antimycotic (Invitrogen, # 
15140-122) at 37 °C in 5% CO2. 
2.1.2 Toxoplasma gondii culture 
Confluent monolayers of HFF were infected with T. gondii. The infected monolayer 
is maintained using Minimum Essential Medium (MEM, Invitrogen, #61100061) 
supplemented with 1% (v/v) fetal bovine serum (FBS, Sigma) and 5 μg/ml antibiotic-
antimycotic (Invitrogen, #15240-062) incubated at 37 °C in 5% CO2. Type I and Type II 
strains of T. gondii (NIH-AIDS Reagent Program, #2859 and #2858) were maintained in 
media without selection. TgAgo-KO strain was obtained from Dr. Boothroyd, Stanford 
University School of Medicine and also maintained in media without selection. TgDicer-
KO was created by Farzana Afrin and maintained in selection media containing 
mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL).  
2.2 Construction of Plasmids for Promoter Reporter Assays 
Primers used for plasmid construction are listed in Table B1. Putative promoter 
sequences were amplified by PCR using Type I genomic DNA as template and performed 
following the manufacturer’s protocol (Phire Hot Start II DNA Polymerase, #F122S). The 
PCR reaction tubes were placed in the 96-well BioRad T100TM Thermal Cycler for 35 
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cycles. Three overlapping regions upstream from exon 1 were amplified from the sense 
strand using primers a, b, c and d to give amplicons of 500, 1135 and 2518 bps, 
respectively. Four overlapping regions downstream from intron 1 were amplified from the 
antisense strand using primers e, f, g, h, and i to give amplicons of 529, 1167, 2159, and 
2670 bps respectively. Amplified fragments were purified by gel extraction using the 
QiaexII Gel Extraction kit (Qiagen, #20021) following the manufacturer's protocol and 
used as inserts in ligation reactions. pTUBRnLuc was digested with NheI and HindIII to 
remove the tubulin (TUB) promoter (2717bps). The linearized pTUBRnLuc plasmid 
(6071bps) was purified using QiaexII Gel Extraction kit (Qiagen #20021) following the 
manufacturer's protocol and used as a vector in ligation reactions. The ligation reaction was 
performed using the Cold Fusion Cloning Kit (System Biosciences, #MC010A-1) or 
NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs, Inc., #E5520S) 
following the manufacturer's protocol. Resultant plasmids carry putative promoters 
upstream from RnLuc coding sequence which would drive RnLuc transcription. Plasmids 
were subjected to restriction endonuclease analyses to confirm their identity before being 
used in the dual luciferase assay.  
2.3 In vitro transcription of TgUlp1 NAT 
2.3.1 Generating Template with T7 Promoter  
Primers used for plasmids construction are listed in Table B3. PCR was performed 
using OneTaq® Quick-Load® 2X Master Mix (New England Biolabs, Inc., #M0485S) 
according to the manufacturer’s protocol to generate DNA templates for the synthesis of 
single- and double-stranded RNA with the sequence encompassing intron 6 and 7 regions 
of TgUlp1 (1,167 bps). T7 promoter sequence was incorporated onto the reverse primer 
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was used to generate single stranded TgUlp1 NAT (ssNAT). T7 promoter sequence on both 
primers was used to generate double stranded TgUlp1 NAT (dsNAT).  
2.3.2 In vitro transcription of NAT 
PCR products were used as a template for T7 transcription. In vitro transcription 
reactions were carried out in 50 μL reaction mixtures in the presence of T7 RNA 
polymerase (~5 units), 80 mM HEPES-KOH, pH 7.5, 24 mM NaCl, 2 mM spermidine, 40 
mM DTT, 10 mM rNTPs, and ~1 unit pyrophosphatase at 37 °C for 16 hours. Reactions 
were subsequently extracted with one volume of phenol-chloroform mixture (1:1), and 
resultant RNAs were precipitated and quantified (Thermo Scientific NanoDraop2000). 
2.3.3 Preparation of Small RNA  
 In vitro transcribed TgUlp1 NAT was treated with ShortCut RNase III prior to 
transfection for dual luciferase assay according to manufacturer’s protocol (New England 
Biolabs, Inc., #M0245S). The products were checked by PAGE analysis.  
2.3.4 PAGE Analysis 
RNase III digestion products of in vitro transcribed TgUlp1 NAT were suspended 
in formamide 2X buffer and separated on a 12.5% denaturing urea gel. The gel was stained 
for 30 minutes with SYBR Gold Nucleic Acid Gel Stain (ThermoFisher Scientific, 
#S11494) in TBE buffer and imaged using BioRad Molecular Imager FX.  
2.4 Electroporation 
Freshly lysed parasites were harvested and used for transfection via electroporation 
using a BTX ECM 630 (1500 volts, 25 Ω, and 25 μF). For each electroporation, 2 µg of  
FFLuc plasmid and varying amounts of RnLuc plasmids were mixed with harvested 
parasites in 400 μL of electroporation mixture (120 mM KCl, 0.15 mM CaCl2, 10 mM 
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K2HPO4/KH2PO4 (pH 7.6) 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione). 
Table B5 lists the type and amount of plasmid electroporated depending on experiment. 
Following electroporation, the parasites were allowed to infect confluent HFF monolayers 
and grown under different conditions depending on the experiment.  
2.5 Dual Luciferase assay 
Parasites were grown under testing conditions (24 hours under neutral pH, 5% CO2, 
or up to 72 hours  under alkali conditions, atmospheric CO2 conditions). The parasites were 
harvested and lysed with 100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and 
incubated for 15 minutes at room temperature. Lysates were cleared of debris by 
centrifugation (12,000 x g for 1 minute) and used in the dual luciferase assay, which was 
carried out in a 2-step fashion. To measure FFLuc activity, 20 μL of lysate was added to a 
freshly made reaction mixture (100 μL) containing 200 μM D-luciferin, 20 mM Tricine, 
10 mM MgSO4, 5 mM DTT, 250 μM ATP and 250 μM Coenzyme A. The mixture was 
incubated for 5 seconds at room temperature and luminescence was measured with a 
20/20n Luminometer (Turner Biosystems). For RnLuc assay, 20 μL of lysate was added to 
a freshly made reaction mixture (100 μL) containing 0.1 μM Coelenterazine, 100 mM 
K2HPO4/KH2PO4 (pH 7.6) 500 mM NaCl, 1 mM EDTA, and 0.02% BSA. The mixture 
was incubated for 5 seconds at room temperature and luminescence measured with a 
20/20n Luminometer (Turner Biosystems). RnLuc activity were normalized to FFLuc 
activity for a direct comparison across independent experiments. Three independent 
experiments were performed for every dual luciferase assay. 
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2.6 RT-PCR Analysis 
2.6.1 RNA Isolation  
Total RNA was isolated from freshly lysed parasites using TriReagent (Molecular 
Research Center, #TR 118) and treated with RQ1 RNase free DNase (Promega, #M6101) 
following manufacturer's protocol. Treated RNA was extracted with one volume of phenol-
chloroform mixture (1:1) three times, and resultant RNA was precipitated and quantified 
(Thermo Scientific NanoDraop2000). Integrity of the RNA was determined by gel 
electrophoresis on 1% agarose gel. Samples were stored at −20 °C for future use.  
2.6.2 Reverse Transcriptase 
First strand cDNA synthesis was performed using ~500 ng isolated total RNA. The 
reaction was performed using Moloney Murine Leukemia Virus Reverse Transcriptase (M-
MLV RT) (New England Biolabs, Inc., #M0253S) following the manufacturer's protocol. 
A negative control reaction in the absence of M-MLV was performed at the same time. 
Samples were stored at −20 °C for future use.  
2.6.3 RT-qPCR 
The cDNA reaction mixtures were diluted 1/1000 dilution for tachyzoite samples 
and 1/10 dilutions for bradyzoite samples and analyzed by using Fast EvaGreen® qPCR 
Master Mix (2x) (Cat #31003) and OneStepPlus thermocycler (Applied Biosystems) 
following the manufacturer’s protocol.  Primers used for RT-qPCR are listed in Table B4. 
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression 
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using 
both biological and technical triplicates.  
 29 
 
2.7 Immunofluorescence Assay 
Cells were fixed in 3% paraformaldehyde in PBS for 10 minutes, permeabilized 
with 0.25% Triton X-100 in PBS for 15 minutes, and non-specific sites were blocked with 
5% equine serum in PBS for 1 hour at room temperature. Slides were incubated for 1 hour 
with FITC-conjugated Dolichos biflorus lectin (1:300, L9142, Sigma) to stain cyst walls 
formed under bradyzoite culturing conditions. Staining of the nuclei was carried out by 
incubation in the presence of Hoechst 33342 solution (3 µM). All images were taken with 
Leica DMI 6000B inverted fluorescent microscope using HCX PL Apo 40x/1.40-0.70 
objective and a Leica DFC 360FX camera in addition to the Leica Application Software 
(LAS).  
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CHAPTER 3 – RESULTS  
3.1 Establishing a Dual Luciferase Reporter to Study Promoters 
To identify the element(s) controlling the expression of TgUlp1 mRNA and NAT, a 
dual reporter assay was used. The term ‘dual’ refers to the use of two individual plasmids 
expressing different reporter proteins. For this study, one of the reporter plasmids 
constitutively expresses firefly (Photinus pyralis) luciferase under the control of previously 
characterized tubulin (TUB) promoter. The activity of FFLuc serves an internal control for 
transformation efficiency and expression level. The second plasmid expresses sea pansy 
(Renilla reniformis) luciferase, under the control of putative promoter sequences for 
TgUlp1 mRNA and NAT. The activity of RnLuc reflects the activity of the regulatory 
sequence being investigated. As the region upstream from the first exon of TgUlp1 mRNA 
and the region downstream from the intron 7 of TgUlp1 locus were hypothesized to carry 
the sense and antisense promoter sequence, three overlapping regions upstream from exon 
1 of TgUlp1 mRNA on the sense strand (SS) and four overlapping regions downstream 
from intron 7 on the antisense strand (AS) were tested (Figure 3.1). These sequences were 
amplified by PCR (Figure 3.2) and placed upstream from the RnLuc CDS (Figure 3.3). 
Resultant plasmids were collectively called pPutPromRnLuc (Table B2). The successful 
expression of RnLuc by the putative promoter was indicative of the sequences’ ability to 
initiate transcription. 
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Figure 3.1 Putative Regions Tested for Promoter Activity  
Schematic representation of the TgUlp1 locus. TgUlp1 has 13 exons indicated as black 
boxes and 12 introns indicated as numbered white boxes.  The region upstream from the 
first exon of TgUlp1 locus was hypothesized to carry the sense promoter sequence 
controlling the transcription of TgUlp1 mRNA (represented by green arrow). Green bars 
upstream from the first exon represent putative promoter sequences on the sense strand 
amplified and tested for sense promoter activity. The region downstream from the intron 7 
of TgUlp1 locus was hypothesized to carry the antisense promoter sequence controlling the 
transcription of TgUlp1 NAT (represented by red arrow). Red bars downstream from the 
intron 7 represent putative promoter sequences on the antisense strand amplified and tested 
for antisense promoter activity. The primers used for PCR analysis and cloning are 
indicated by letters and arrows and listed in Table B1.  
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Figure 3.2 Representative Gel Image of PCR Analysis of Putative Promoters 
Primer sets a-b, a-c, and a-d were used to amplify 0.5-kb, 1.0-kb, and 2.5-kb regions on the 
sense strand upstream from exon 1. Primer sets e-g, e-h, f-i and e-i were used to amplify 
0.5-kb, 1.0-kb, 2.5-kb and 2.0-kb regions on the antisense strand downstream from intron 
7. Amplicons were gel purified and cloned into plasmid construct to control the expression 
of RnLuc.  
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Figure 3.3 Plasmid Constructs Used in the Promoter Assays  
In the plasmid pTUBRnLuc, the expression of Renilla luciferase (RnLuc) is under the 
control of tubulin (TUB) promoter. This plasmid was used as a positive control for an 
active promoter.  The plasmid pRnLuc lacking a promoter was used as a negative control 
for background activity. In the test RnLuc plasmids – collectively called pPutPromRnLuc 
– the TUB promoter was replaced with putative promoter sequences from the TgUlp1 locus 
from the sense strand (green – 0.5-kb, 1.0-kb, or 2.5-kb) or the antisense strand (red – 0.5-
kb, 1.0-kb, 2.5-kb, or 2.0-kb). A successful expression of RnLuc by a putative promoter is 
indicative of the sequence promoter activity. The plasmid pTUBFFLuc codes for Firefly 
luciferase (FFLuc) under the control of a TUB. All RnLuc activities are normalized to 
FFLuc activity.   
TUB RnLuc CDS pTUBRnLuc (Positive Control) 
RnLuc CDS pRnLuc (Negative Control) 
pTUBFFLuc (Internal Control) TUB FFLuc CDS 
pPutPromRnLuc (Test) 
Rn CDS 
1.0-kb 
0.5-kb 
1.0-kb 
2.5-kb 
0.5-kb 
2.0-kb RnLuc CDS 
RnLuc CDS 
RnLuc CDS 
RnLuc CDS 
RnLuc CDS 
RnLuc CDS 
2.5-kb RnLuc CDS 
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The activity of pTUBRnLuc was used to establish maximum promoter activity. The 
activity of the pRnLuc – no promoter – was used to establish the threshold for background 
activity. When equal amounts of pTUBRnLuc and pRnLuc (5 µg) were electroporated and 
the activity was compared, we found that the activity of the plasmid with TUB promoter 
was approximately 70x greater than no promoter (Table 3.1). This establishes a wide range 
over which the activity of putative promoters can be compared.  
 
Table 3.1  RnLuc Activity of Control Plasmids for Promoter Assay 
Plasmid Plasmid (µg) Trial 1 Trial 2 Trial 3 Average 
pRnLuc 5 168 205 204 192 
pTUBRnLuc 5 15072 10311 15190 13524 
p2.5kbSSRnLuc 5 441 413 245 366 
 
 
Next, the activity of TUB promoter was compared to putative 2.5-kb SS promoter. 
Both promoters are approximately the same in length (~2.5-kb), thus differences in activity 
would be result from differences in sequences. The activity of different dilutions of TUB 
promoter plasmid were compared to 5 µg of putative 2.5-kb SS promoter. As shown in 
Figure 3.4, the activity of 2.5-kb SS is 100x-1000x lower than TUB activity. 
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Figure 3.4 Relative Luciferase Activity of Putative 2.5-kb TgUlp1 mRNA 
promoter Compared to Strong Tubulin Promoter  
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc 
activity. The green bar represents the activity of the 2.5-kb putative promoter on the sense 
strand (5 µg). Gray bars represent the activity of TUB promoter in varying amounts and 
black bars represent activity of no promoter (5 µg). Activity of the 2.5-kb sense putative 
promoter was compared to 10-fold dilutions of the TUB promoter. Error bars represent 
SEM (n = 3). 
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3.2 Identifying TgUlp1 mRNA and NAT Promoters  
With the promoter assay established, the next aim was to identify the sequence 
controlling TgUlp1 mRNA and NAT expression. Promoter activity was measured in 
tachyzoite and bradyzoite stages of T. gondii life cycle in both Type I and Type II strains 
to determine if life stage or strain had any effect on promoter activity.  RnLuc and FFluc 
plasmids were electroporated into freshly lysed parasites, grown for 24 hours and then 
collected to measure luciferase expression. Relative RnLuc/FFLuc activity of each putative 
promoter was compared to the activity of no promoter as opposed to the highly active TUB 
promoter. This allowed me to determine which putative promoter was significantly active.    
In Type I tachyzoites (Figure 3.5 – solid bars), the 1.0-kb SS and the 2.0-kb AS 
show a significant increase in RnLuc expression when compared to no promoter. The 
promoter assay in Type II revealed that the same 1.0-kb SS and the 2.0-kb AS putative 
promoters have high RnLuc expression (Figure 3.5 – dotted bars), however only the 2.0-
kb AS is statistically significant. Activity for all pPutPromRnLuc is similar between the 
strains which indicates that strain differences do no affect TgUlp1 mRNA and NAT 
promoter activity.  
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Figure 3.5 Promoter Activity in Type I and Type II T. gondii Tachyzoites 
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc 
activity. Green bars represent activities of sense strand promoters, red bars represent 
activities of antisense strand promoters and black bars activities of represent no promoter. 
Solid bars represent activity in Type I, and dotted bars represent activity in Type II. The 
1.0-kb region on the sense strand and 2.0-kb region on the antisense strand have the highest 
RnLuc expression when compared to no promoter in both Type I and Type II. Error bars 
represent SEM (n = 3). *P < 0.05; compared to no promoter control, unpaired two-sided t-
test.   
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3.3 TgUlp1 mRNA and NAT Promoter Activity in Bradyzoites 
Immunofluorescence assay was performed to confirm both Type I and II strains 
ability and efficacy to convert to bradyzoites. Culturing the infected HFF monolayers under 
a high pH (~8) and low CO2 (0.05% atmospheric level) is commonly used to convert 
tachyzoites to bradyzoites [54]. Tachyzoites were allowed to infect confluent HFF 
monolayers. After 6 hours, the media was changed to alkali conditions to allow conversion 
for another 24 hours. Cells were fixed and stained with FITC-conjugated Dolichos biflorus 
lectin (Dol-FITC). Dol-FITC labels the cyst walls that is specific to the bradyzoite life stage 
of the parasite. As shown inFigure 3.6, cyst walls were detected within 24 hours with both 
Type I and Type II parasites.  
To evaluate whether the putative promoters were active under alkali growth 
conditions, the promoter assay was performed in Type I bradyzoites after 24 hr incubation 
in alkali media. Figure 3.7 shows that the 1.0-kb SS and 2.0-kb AS region have the highest 
activity for RnLuc expression. However, only the 2.0-kb AS promoter is significant when 
compared to no promoter. Due to the high similarity in promoter activity between in Type 
I and II tachyzoites, it was assumed that Type I and II bradyzoites would also have a similar 
pattern of activity.   
Bases on these promoter assays, the promoter for TgUlp1 mRNA was identified to 
be located within the 1.0-kb SS region upstream from exon and the promoter for TgUlp1 
NAT was identified to be located within the 2.0-kb AS region located downstream from 
intron 9. Their activities by promoter assay indicates that both sense and antisense 
promoters are active in tachyzoites, but only the antisense promoter is active in bradyzoites.  
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Figure 3.6  Immunofluorescence Assay of Cyst Formation in Type I and II T. 
gondii.  
Tachyzoites were used to infect confluent HFF monolayers. After 6 hours, the parasites 
were grown under alkali conditions for another 24 hours then stained with Hoechst (Hz) 
and a cyst-specific FITC conjugated lectin (Dol-FITC). Slides were microscopically 
examined for bradyzoite conversion indicated by the presence of a cyst wall. Scale bars 
represent 10 μm.  
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Figure 3.7  Relative activity of RnLuc Under the Control of Putative Promoters in 
Type I T. gondii Bradyzoites. 
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc 
activity. Green bars represent activities of sense strand promoters, red bars represent 
activities of antisense strand promoters and black bars represent activities of no promoter. 
The 2.0-kb region on the antisense strand shows significant increase in RnLuc expression 
when compared to no promoter. Error bars represent SEM (n = 3). *P < 0.05; compared to 
no promoter control, unpaired two-sided t-test.   
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Our next aim was to investigate the pattern of expression when the identified 
promoters of TgUlp1 mRNA and NAT were analyzed over longer incubation in alkali 
media. Type II was used for further study in bradyzoites due to their ability to switch to 
bradyzoite more easily and higher clinical relevance. Type II parasites were switched to 
alkali media 6 hours after electroporation and incubated in alkali media for 24hr, 48hr and 
72 hr before being collected for the dual luciferase assay. As shown in Figure 3.8, the sense 
promoter activity decreases slightly but does not show any significant changes over time. 
The antisense promoter shows a steep decrease in activity at 24 hours which remains 
consistent up to 72 hours.  
 
 
 
Figure 3.8 Change in Sense and Antisense Promoter Activity in Type II 
Bradyzoites 
Relative RnLuc activity was measured and normalized to that of co-transfected FFLuc 
activity. Solid bars represent expression of the promoters in tachyzoites (Tz) and striped 
bars represent expression of the promoters after incubation in alkali media. Error bars 
represent SEM (n = 3). 
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3.4 TgUlp1 mRNA and NAT Expression  
The promoter assay suggested that transcription of TgUlp1 mRNA and NAT is 
differentially regulated between tachyzoites and bradyzoites.  To further confirm this, RT-
qPCR was performed in Type II parasites to determine the level of TgUlp1 mRNA and 
NAT expression. Total RNA was collected from freshly lysed parasites for tachyzoite 
samples, and after incubation in alkali media for 24 hours for bradyzoite samples. Both 
TgUlp1 mRNA and NAT were detected in tachyzoites. After conversion to bradyzoites, 
TgUlp1 mRNA was detected to be 10x lower but TgUlp1 NAT was 60x higher (Figure 
3.9). 
 
 
Figure 3.9 Expression of TgUlp1 mRNA and NAT in Tachyzoites and Bradyzoites  
Bradyzoite samples were collected after growing for 24 hours in alkali media. The cDNA 
reaction mixtures were diluted 1/1000 dilution for tachyzoite samples and 1/10 dilutions 
for bradyzoite samples. Relative TgUlp1 mRNA and NAT expression levels in comparison 
to GAPDH expression levels were measured and calculated using 2-ΔΔCt protocol. RT-
qPCR were analyzed using both biological and technical triplicates. Error bars represent 
SEM. 
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3.5 The Effect of TgUlp1 NAT on Gene Expression  
3.5.1  Structural Analysis of TgUlp1 NAT  
It has been hypothesized that TgUlp1 NAT is a precursor for short regulatory RNAs 
belonging to miR60 family [53], which are capable of regulating the expression of  TgUlp1 
mRNA expression. The RNA structure prediction algorithm Mfold [55] was used to 
generate secondary structures for a further analysis of TgUlp1 NAT as the substrate of 
Dicer. Being the key enzyme of RNAi, Dicer recognizes hairpin (stem-loop) structures of 
transcripts and cleaves them to yield short double-stranded RNA products of approximately 
21-23 bps with 3’-overhang to guide RNA-silencing complexes. Based on the most stable 
predicted structure shown in Figure 3.10, various locations with hairpin structures could 
serve as the substrates to produce miRNA. The sequences of the hairpin structures are 
shown in Table 3.2. The sequence from the potential miRNA were used to predict 
interactions with the sense transcript. For example, hairpin #1 will give a miRNA product, 
whose upper strand can recognize TgUlp1 transcript at the nucleotides +4786 to +4806 in 
the intron 2. The lower strand can recognize TgUlp1 transcript at the nucleotides +2809 to 
+2828 in the intron 2.  
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Figure 3.10 TgUlp1 NAT Structure Prediction 
Predicted secondary structure of TgUlp1 NAT using Mfold.  It contains many hairpin loops 
(indicated by black arrows) that maybe processed by Dicer to generate miRNA.  
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Table 3.2 Stem Loops Predicted to be Cleaved by Dicer  
Yellow highlights indicate Watson-Click base pairing, and green highlights indicate 
wobble (G:U) pair. Green and red bases are from step loop and black bases are from 
TgUlp1 transcript.  
Stem Loop Sequence Matches on TgUlp1 Locus 
Hairpin #1 (45nts) 
 
 
                    AGAA  
5’ UGUUACGGUCACCUGGA     G 
   ||:| ||||  ||  |      G 
3’ ACGACGCCAA GGGUCAACAGAG 
                    ACAG    
 
 
 
Exon 1 
+2809 to +2828 
5’ CTCCTCAGCCTTCGCGTCTT 3’ 
3’ ACGACGCCAAGGGUCAACAG 5’ 
 
Intron 2 
+4786 to +4806 
5’ TTCTGCGAGAAAAACGAAAGA 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
 
Intron 2 
+5183 to +5203 
5’ TTTTTCTACGCGCGCGTCAGA 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
 
Intron 3 
+5635 to +5655 
5’ CTCTCCTAGGTGAGCATCAGC 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
 
Intron 6 
+7051 to +7070 
5’ CTCTTTACCCTTGGTCTGGC 3’ 
3’ ACGACGCCAAGGGUCAACAG 5’ 
 
Intron 6 
+7096 to +7116 
5’ TGGTTCTGCAGGAGCGTAACA 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
 
Exon 8  
+7771 to +7791 
5’ TTCTTCTACGCGAAGCTGACG 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
 
Exon 9 
+8237 to +8256 
5’ CACTGGACTCTCGGCGTCGT 3’ 
3’ ACGACGCCAAGGGUCAACAG 5’ 
 
Intron 9 
+8275 to +8295 
5’ TGGATCCACGTGACAGTTTCT 3’ 
3’ AAGAAGGUCCACUGGCAUUGU 5’ 
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Hairpin #2 (46 nts) 
 
 
                       U G 
5’ GACGAGAAUGAACGUACUUU    U 
   :||:||||  ||||  ||:|    C 
3’ UUGUUCUUCGUUGCGCGAGA    C  
                       C C 
 
5’-Flanking 
+2061 to +2080 
5’ AAAAAACGGCCTTTCCCGTG 3’ 
3’ UUUCAUGCAAGUAAGAGCAG 5’ 
 
Intron 1 
+4079 to +4098 
5’ ATCTTTCCTTCCTTCTCGCC 3’ 
3’ UUUCAUGCAAGUAAGAGCAG 5’ 
 
Intron 5 
+6552 to +6571 
5’ CCTCTACTTTCATGCTCGTC 3’ 
3’ UUUCAUGCAAGUAAGAGCAG 5’ 
 
Intron 6 
+7073 to +7092 
5’ ACATTTCCGTCCTTCTTGTC 3’ 
3’ UUUCAUGCAAGUAAGAGCAG 5’ 
Hairpin #3 (57 nts) 
 
 
                                 C      
5’ CUCGAG CAA GAG AAAG  GCACCGUC   C  
   ||||||     |||       :|||| ||    G  
3’ GAGCUCA   GCUC       UGUGG AG   A    
          CAG    ACAGACA         C             
  
 
 
 
 
5’-Flanking 
+2149 to +2172 
5’ GAATTTTCCCTTCTCTTGTCCTGG 3’ 
3’ CUGCCACGGAAAGAGAACGAGCUC 5’ 
 
Intron 9 
+8410 to +8433 
5’ TGGGGTGTCTTGCCCTTACTGCAG 3’ 
3’ CUGCCACGGAAAGAGAACGAGCUC 5’ 
 
Intron 12 
+9573 to +9596 
5’ GATGGTGAGTGTCTTTTGCGGGTG 3’ 
3’ CUGCCACGGAAAGAGAACGAGCUC 5’ 
 
3’-Flanking 
+10614 to +10641 
5’ TCGATCTGCCGCGTGTCTCTTCTCCT 3’ 
3’ AGGUGUACAGACACUCGGACACUCGA 5’ 
 
  
 47 
 
3.5.2  NAT and its Derivatives on the Expression of RnLuc Transcripts 
A dual reporter system was used to determine if TgUlp1 NAT and its derivatives 
have a regulatory effect. For this study, both of the reporter plasmids constitutively and 
individually express FFLuc or RnLuc under the control of TUB promoter to ensure a high 
level of expression. While the FFLuc activity serves as an internal control for 
transformation efficiency and expression level, the RnLuc activity will reflect the 
regulatory effect of TgUlp1 NAT and its derivatives. The RnLuc transcripts were 
engineered to carry various portions of TgUlp1 mRNA containing predicted miRNA 
binding sites (25 nts), referred to as site A or B (Figure 3.11). These miRNA binding sites 
were placed at the 3’-UTR of the RnLuc transcript. Both constructs were electroporated 
along with single stranded NAT (ssNAT) and ssNAT digested with RNase III (NAT-R). 
NAT-R was confirmed to produce short RNA using gel electrophoresis. It was observed 
that ssNAT was able to lower RnLuc expression by 55 ± 2.4% and 40 ± 1.8% for constructs 
A and B respectively (Figure 3.12). NAT-R was also able to lower RnLuc expression by 
47 ± 1.2% and 41 ± 1.6% for constructs A and B respectively.  
The promoter assay suggests that both TgUlp1 mRNA and NAT transcription is 
active in tachyzoites. Thus, it is possible that  TgUlp1 mRNA and NAT form dsRNA which 
may confer a regulatory effect on TgUlp1 mRNA expression. To test this, we 
electroporated constructs A and B with long double stranded NAT (dsNAT, 1167bps). In 
Figure 3.12, we see that  dsNAT did not have an effect on RnLuc expression. 
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Predicted mRNA Binding Site Sequence Location on TgUlp1 mRNA 
5’ CGUCCUGGACACAAGGACGACUAUCU 3’ 
Exon 1/2 Junction 
(+1165 to +1190) 
(Site A) 
5’  UGCCAUGCAUGGAAAGAAAUGUGUG 3’ 
3’ Flanking Region 
(+2700 to +2725) 
(Site B) 
 
 
Figure 3.11 Predicted Binding Sites on TgUlp1 mRNA Used To Detect Self-
Regulation By TgUlp1 NAT 
Two sequences on the TgUlp1 mRNA were tested for self-regulation. Site A is in the CDS 
spanning the exon 1/2 junction (+1165 to +1190). Site B is in the 3’-UTR (+2700 to 
+2725). The sites were cloned downstream of the RnLuc CDS in pTUBRnLuc so that the 
3’-UTR of the RnLuc transcript would carry the either Site A or B sequences. These 
constructs were used in a dual luciferase assay.  
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Figure 3.12 Effect of TgUlp1 NAT on Engineered RnLuc Expression 
Relative RnLuc activity was obtained and normalized to that of co-transfected FFLuc 
activity. Construct A and B were electroporated with and without 5 µg of in vitro 
transcribed single stranded (ss), double stranded (ds) or RNase III Digested (-R) TgUlp1 
NAT to determine its’ effect on RnLuc expression. pTUBRnLuc (no site) was used to 
establish basal RnLuc activity without any binding sites. ssNAT and NAT-R were able to 
lower the expression of both constructs RnLuc carrying predicted miRNA binding sites 
from TgUlp1 mRNA. Error bars represent SEM (n = 3). *P < 0.05; compared to no RNA, 
unpaired two-sided t-test. 
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3.6 Effect of TgUlp1 NAT on the level of TgUlp1 mRNA  
The dual luciferase assay suggested that TgUlp1 NAT could be a precursor for 
miR60 family that regulates the expression of RnLuc transcripts. To determine the effect 
of TgUlp1 NAT on the expression of mRNA, ssNAT was electroporated into Type II 
parasites and mRNA expression was measured by RT-qPCR. Figure 3.13 describes the 
experiment flow. Lysed parasites were electroporated with (+) and without (mock, -) 
ssNAT. RNA samples were collected after 24 hours to determine the immediate effect of 
ssNAT. Parasites were subcultured twice, and RNA was collected after each subculture to 
observe changes in TgUlp1 mRNA expression. In Figure 3.14, we observed that after mock 
electroporation, mRNA level dropped approximately 10x and stayed consistently low for 
120 hours post electroporation.  When ssNAT is electroporated, mRNA expression is 
unaffected compared to mock (Figure 3.14). We also measured TgUlp1 NAT level after 
mock electroporation. In Figure 3.15, we see mock electroporation caused an increase NAT 
expression by approximately 10x which is consistent for 120 hours post electroporation.  
Due to the changes in TgUlp1 mRNA and NAT level caused by electroporation process 
itself, we were unable to determine if NAT had an effect on the level of TgUlp1 mRNA.  
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Figure 3.13 Experiment Flow for Detecting Effect of in vitro NAT  
Lysed parasites were electroporated with (+) and without (mock, -) ssNAT. RNA samples 
were collected after 24 hours to determine the immediate effect of ssNAT. Parasites were 
subcultured twice, and RNA was collected after each subculture to observe changes in 
TgUlp1 mRNA expression. Tz refers to tachyzoites and EP refers to electroporation.  
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Figure 3.14 TgUlp1 mRNA Expression After Mock and in vitro NAT 
Electroporation 
Striped bar represents mRNA expression after mock electroporation and solid bars 
represent mRNA expression after in vitro NAT electroporation. Relative TgUlp1 mRNA 
expression levels in comparison to GAPDH expression levels were measured and 
calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using both biological and 
technical triplicates. Error bars represent SEM.   
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Figure 3.15 TgUlp1 mRNA and NAT Expression After Mock Electroporation 
Striped green bar represents TgUlp1 mRNA expression after mock electroporation and 
striped red bars represent TgUlp1 NAT expression after in vitro NAT electroporation. 
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression 
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using 
both biological and technical triplicates. Error bars represent SEM.  
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3.7 TgUlp1 mRNA and NAT Expression in TgDicer-KO and TgAgo-KO 
To further evaluate whether RNAi is involved in the expression of TgUlp1 mRNA 
and NAT, RT-qPCR analysis was performed in TgDicer-KO and TgAgo-KO strains. 
TgDicer-KO was created by a previous student by inserting the YFP HX gene in frame 
with the TgDicer gene. TgDicer-KO is incapable of digesting lncRNA, such as the 
hypothesized TgUlp1 NAT. TgAgo-KO was created by replacing the entire TgAgo gene 
with hypoxanthine-xanthine guanine phosphoribosyl transferase (HXGPRT) as a 
selectable marker. TgAgo-KO strain has reduced gene silencing ability. RT-qPCR 
performed show that TgUlp1 NAT levels is approximately 7x higher in both KO strains 
compared to its parental strain. TgUlp1 mRNA levels in both KO strains are approximately 
10x lower (Figure 3.16).  
 
 
Figure 3.16 TgUlp1 mRNA and NAT expression in TgDicer-KO and TgAgo-KO 
compared to its’ parental  
Relative TgUlp1 mRNA and NAT expression levels in comparison to GAPDH expression 
levels were measured and calculated using 2-ΔΔCt protocol. RT-qPCR were analyzed using 
both biological and technical triplicates. Error bars represent SEM.  
0.03
0.13
0.50
2.00
8.00
32.00
128.00
Parental TgDicer-KO TgAgo-KO
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
(L
o
g
2
 S
c
a
le
)
mRNA
NAT
 55 
 
CHAPTER 4 – DISCUSSION 
4.1  Promoters for TgUlp1 mRNA and NAT  
To establish the promoter assay, we used the highly expressed β-tubulin (TUB) 
promoter controlling the activity of the RnLuc reporter in setting an upper limit of 
detection, and the RnLuc construct without a promoter in setting a lower limit of 
background detection. There are multiple advantages for using RnLuc and FFLuc. First, 
the assay is highly reliable. Both enzymes are stable for more than one hour while providing 
a luminescent signal using independent substrates: coelenterazine for RnLuc and D-
luciferin for FFLuc. Second, both enzymes have  a linear range covering eight orders of 
magnitude, which allows for the detection of approximately 0.1 femtogram (approximately 
10–21 mole) of enzyme [56]. Therefore, the assay provides highly sensitive measurement 
of gene expression analysis. The reliability, stability and sensitivity of dual luciferase 
assays have allowed us to establish an assay to identify the promoters for TgUlp1 mRNA 
and NAT.  
In eukaryotes, two core components constitute a functional promoter. These DNA 
sequences often referred to as core promoter and proximal promoter [57]. The core 
promoter contains the RNA polymerase binding site, TATA box, and transcription start 
site (TSS). The proximal promoter contains sequences that bind transcription factors and 
is found approximately 250-bps upstream from the TSS. The sequences and locations of 
these promoter elements contain a certain degree of conservation. Therefore, mapping and 
functional analysis are essential in gaining a better understanding of these elements. To 
study the promoter controlling the expression of TgUlp1 mRNA and NAT, we began by 
choosing an arbitrary 2.5-kb region upstream from exon 1 to map the putative promoter 
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controlling TgUlp1 mRNA, and 2.5-kb region downstream from intron 7 to map TgUlp1 
putative promoter controlling TgUlp1 NAT. Starting with the 2.5-kb 5’-flanking region of 
TgUlp1 locus as the expression of TgUlp1 is well characterized (Figure 3.1), we compared 
the activity of this region to TUB promoter and found that the putative TgUlp1 mRNA 
promoter activity was 100x-1000x lower. This expression level agrees with microarray 
analysis published by ToxoDB for TgUlp1 (TGGT1_2144700) and TgTUB 
(TGGT1_266960), as TgUlp1 is shown to express at a lower level than TUB [58]. Further 
mapping of the region identified the promoter for TgUlp1 mRNA to be the 1.0-kb region 
upstream from exon 1 on the sense strand. Although it is shorter than the TUB promoter 
we used, it agrees with the minimal and function promoter controlling TUB [59]. The 
promoter of  TgUlp1 NAT was identified to be the 2.0-kb region between from intron 9 
(+5768) to 3’-flanking region (+7920) on the antisense strand (Figure 4.1).  
So far, well-characterized motifs such as TATA box have not been observed in T. 
gondii core promoters [60]. However, there is evidence that other motifs are important for 
transcription in T. gondii such as the initiator element (Inr). Inr is a core promoter, 
commonly found in genes that lack TATA box and the most common sequence found at 
the TSS of eukaryotic genes [61]. Using ElemeNT, we identified Inr in the promoter for 
TgUlp1 mRNA and NAT (Table B6). We can also identify other important motifs such as 
GAGACG and TGCATGC in the identified promoter for TgUlp1 mRNA and NAT as 
shown in Table B7 and Table B8. GAGACG has been identified as a critical element in 
many T. gondii promoters [62]. In fact, it has been suggested that this motif might be the 
T. gondii  equivalent to TATA box seen in other eukaryotes [32]. TGCATGC is the 
putative binding motif for apicomplexan AP2 (ApiAP2) family of transcription factors and 
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conserved in other members of the apicomplexan phylum including T. gondii  [63]. This 
motif is found in hundreds of T. gondii promoters. Inr, GAGACG, and TGCATGC motifs 
were found almost exclusively within the identified promoter regions for TgUlp1 mRNA 
and NAT. 
TgUlp1 NAT 2.0-kb promoter exhibits the highest RnLuc activity but is not 
immediately upstream from intron 7 of the antisense transcript detected, as shown in Figure 
4.1 [53].  
 
 
Figure 4.1  Identified Promoters of TgUlp1 mRNA and NAT  
Green and red bar represents the promoter region for TgUlp1 mRNA and NAT 
respectively. Green and red arrows represent the transcription of TgUlp1 mRNA and NAT 
respectively. * indicates a 500-bps region between the detected TgUlp1 NAT and its 
identified promoter.  
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assay, such as those used in the study, can be modified for the study. The second 
1   1 2 3 4 5 6 7 8 9 10 11 12 
* 
Exon 
 
Intron 
 
5’ and 3’ Flanking Regions 
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explanation is due to our lack of information on the TSS features. Currently the full length 
of TgUlp1 NAT has not yet been characterized, and its 5’-end could start in within this 
starred region. For future work, one can map the 5’-end of TgUlp1 NAT by using a 
technique called primer extension [64]. This technique requires a radiolabeled primer 
complementary to a region on the transcript. The primer anneals to the transcript and 
reverse transcriptase is used to synthesize cDNA until it reaches the 5'-end of the transcript. 
The transcript-cDNA hybrid is denatured, and cDNA product is analyzed on a sequencing 
gel. Rapid amplification of cDNA ends (RACE) is another technique that can be used to 
obtain the full length sequence of a transcript [65]. Similar to primer extension, this 
technique generates cDNA using a gene specific primer and reverse transcriptase. After 
first strand cDNA synthesis, the original transcript template is treated with RNase and an 
oligonucleotide adapter is linked to the 3’-end of the cDNA. Thereafter, PCR is performed 
using a gene specific primer and primer for the adapter to amplify the region with the 5′ 
unknown sequence. PCR products are then cloned into a vector for sequencing.  
4.2  Expression Of TgUlp1 mRNA And NAT During Its Asexual Cycle 
T. gondii pathogenicity comes from its ability to differentiate between tachyzoites 
and bradyzoites to evade the host immune response. Thus, a better understanding of the 
molecular mechanisms that drive stage conversion between tachyzoites and bradyzoites is 
necessary to manage transmission and pathogenesis of T. gondii. Many studies have 
documented genes that are exclusively expressed in either tachyzoites or bradyzoites, 
suggesting that different expression of gene play a major role in coordinating transitions 
in T. gondii  [66]. However, studies in differential regulation in T. gondii have focused on 
protein-coding genes. In this study, I focus on antisense gene regulation and observed that 
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TgUlp1 NAT is differentially regulated at the transcriptional level. In tachyzoites, both 
identified promoters are active which indicates TgUlp1 mRNA and NAT transcription may 
be occurring at the same time. This was further confirmed by RT-qPCR which detects the 
presence of both sense and antisense transcripts in tachyzoites. In bradyzoites we observe 
a lower sense promoter activity bradyzoites in agreement with lower TgUlp1 mRNA 
expression. However, despite a decrease in antisense promoter activity, RT-qPCR shows 
us that TgUlp1 NAT expression is higher in bradyzoites compared to tachyzoites. This 
indicates that although antisense promoter might be less active in bradyzoites, the antisense 
transcript turnover is slower. In addition, time course experiment showed no change in 
promoter activity with longer incubation in alkali conditions. Taken together, the promoter 
assay and RT-qPCR suggested that the expression of TgUlp1 NAT and mRNA are 
differentially regulated at the transcriptional and post- transcriptional level via promoter 
activity and transcript turnover.  
Although the promotor assay has been useful in discriminating between active and 
nonactive promoter sequences, the discrepancy between promoter activity and transcript 
suggested other mechanisms are involved. For example, differences in transcript stability 
between TgUlp1 mRNA and NAT and RnLuc would affect our measurements for promoter 
activity.  In addition,  distal regulatory elements and chromatin modification are a common 
feature of the eukaryotic genome which are responsible for transcriptional regulation [67]. 
In a reporter system, the promoter is stripped of this genomic context which may lead to 
non-specific promoter activity.  
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4.3 TgUlp1 NAT and its Regulatory Effect  
ncRNA molecules have generally been discovered by large-scale sequencing 
projects that were carried out for various model organisms, such as humans, mice and 
worms. Similarly, large-scale sequencing projects of Apicomplexan parasites have 
confirmed the presence of long and short ncRNAs, including NATs and miRNA [30, 31]. 
However, the discovery of TgUlp1 NAT was fortuitous. During the study of TgUlp1 
mRNA as a potential target of miR60 family, NAT was discovered by gene specific RT-
PCR [53]. The fact that TgUlp1 is the first gene confirmed as the target of miR60 family 
led us to hypothesize that TgUlp1 NAT, as a lncRNA species, is a regulatory RNA. To test 
this hypothesis, we adopted two strategies. One was an in silico analysis of TgUlp1 NAT 
as the precursor of miRNAs. The analysis of TgUlp1 NAT showed several potential 
miRNAs whose sequence are highly complementary to TgUlp1 mRNA (Table 3.2).  
Our second strategy was to use a dual luciferase system in determining the 
regulatory effect of TgUlp1 NAT (ssNAT) and its RNase-III digested products (NAT-R). 
To create the reporter transcript for this experiment, we placed the sequence of predicted 
binding site at the end of RnLuc CDS and in the 3’-UTR. Such a reporter construct is 
commonly used in the study of siRNA and miRNA silencing function [68, 69]. We detected 
that ssNAT and NAT-R were able to downregulate RnLuc expression. This indicates that 
as a lncRNA, TgUlp1 NAT could yield short regulatory ncRNAs. It is highly likely that 
the short regulatory ncRNAs have the structural features of miRNAs. It should be noted 
that these short regulatory ncRNAs were previously shown to have similar down-regulation 
effect as those of miR60 family [53]. As both sense and antisense promoters are active in 
tachyzoites, it is also possible that both transcripts could form perfect-paired double-
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stranded RNA that could affect the regulation of TgUlp1 mRNA. However, we did not 
detect that the long double-stranded RNA of NAT (dsNAT) has silencing activity. It would 
be interesting to further test whether the RNase III products of long double-stranded RNA 
of NAT can exhibit similar activity as those of ssNAT and NAT-R. Consequently, it would 
imply that TgUlp1 NAT and its counter mRNA form dsNAT and serve as a siRNA 
precursor.  
When we analyzed the predicted secondary structure of TgUlp1 NAT, we found 
multiple stem loops that could be substrates for Dicer. We analyzed the predicted products 
against mRNA and found multiple sites which may be targeted by TgUlp1 NAT derivatives 
to regulate expression. To identify if the loops we predicted were actually miRNA 
precursors, one can perform northern blot of in vitro NAT-R products. By probing for the 
stem loop sequences predicted as Dicer cleavage sites, we can confirm if TgUlp1 NAT 
produces short regulatory RNA.  In addition, one can sequence NAT-R products and look 
for a match on the TgUlp1 transcript. If a match between the sequenced NAT-R products 
and TgUlp1 transcript is found, it will provide a more specific and likely target to test for 
self regulation of TgUp1. To determine if Dicer is involved in processing TgUlp1 NAT 
endogenously, one could also perform northern blot in TgDicer-KO and probe for TgUlp1 
NAT. 
Since ssNAT and NAT-R were able to downregulate the expression of RnLuc  
carrying predicting binding sites derived from the TgUlp1 mRNA, we speculated that 
TgUlp1 NAT would directly affect the level of TgUlp1 mRNA. However, we are unable 
to conclude if TgUlp1 NAT has a direct effect on mRNA levels. Instead, we observed that 
the stress of electroporation alone affected TgUlp1 transcript levels; mRNA level 
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decreased, and NAT levels increased and remained consistent up to 120 hours. This 
indicated TgUlp1 NAT may play a role in the parasite’s stress response. To further study 
the effect and role of TgUlp1 NAT in the response, one can alter the expression of TgUlp1 
NAT by repressing the transcription of TgUlp1 NAT using CRISPR interference 
(CRISPRi) [70]. This repurposed CRISPR/Cas9 system requires an inactive version of 
Cas9 (dCas9) which was created by two point mutations in its RuvC-like (D10A) and HNH 
nuclease (H840A) domains [71]. These mutations allow dCas9 to bind double stranded 
DNA, but it no longer has endonuclease activity. Directed by a single guide RNA, the 
dCas9 will bind at the promoter we identified by the dual luciferase assay. Once bound, it 
would interfere with transcription initiation and lead to TgUlp1 NAT knockdown. 
Interrupting the expression of TgUlp1 NAT will allow us to measure its effect on the 
mRNA by RT-qPCR. If TgUlp1 NAT is essential to the regulation of TgUlp1, we would 
expect to see change in mRNA levels when NAT decreases. Previous studies using 
CRISPRi show that this system is good for studying overlapping transcription units [71], 
such as in the case of TgUlp1 mRNA and NAT. Traditional knockdown methods such as 
a RNAi have several limitations. First, knocking down antisense transcript require 
exogenous siRNAs to carry sense transcript sequences. Second, unlike protein-coding 
genes, many lncRNAs primarily localize in the nucleus.  Even though RNAi machinery 
has been found to be active in the nucleus, siRNAs against nuclear lncRNAs have often 
proven to be less effective [71].  
4.4  Dicer and Ago Knockout Strains of Toxoplasma gondii 
Dicer and Argonaute are key ribonuclease of the silencing pathways mediated by 
small ncRNAs, including siRNA and miRNA. Logically, if TgUlp1 NAT is a precursor 
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short regulatory ncRNA, it would depend on Dicer and Ago to regulate mRNA expression. 
We expected to detect a higher expression of TgUlp1 mRNA in both knockout strains. 
However, we detected that TgDicer-KO and TgAgoKO have a much lower level of TgUlp1 
mRNA and a higher level of TgUlp1 NAT in comparison to the parental strain, indicating 
that Dicer and Ago are involved in maintaining TgUlp1 mRNA.  
A study by Napoli et al., [72] looked at self-regulation of the oncogene c-MYC by 
its NAT. They found that, the c-Myc NAT is processed by Dicer to produce short regulatory 
RNA and that Dicer knockdown resulted in a lower mRNA level and higher NAT level. 
They speculated that because DICER is also involved in chromatin modifications, c-Myc 
sense and antisense transcripts were regulated by altering the chromatin state. To test this, 
they treated Dicer knockout cells with HDAC inhibitor which induced acetylation of 
histones at c-Myc locus, further reducing mRNA and increasing NAT levels. This provides 
evidence that altering chromatin states regulate c-Myc NAT transcription, which in turn 
may negatively regulate c-Myc mRNA expression. Although my study did not look at 
epigenetic regulation of TgUlp1 NAT, studying this relationship would provide more 
insight on antisense regulation in T. gondii.  
Interestingly, we see a very similar pattern of expression for TgUlp1 mRNA and 
NAT when we compare RT-qPCR results between bradyzoites, mock electroporation, 
TgDicer-KO, and TgAgoKO. In each experiment, there was a higher level of TgUlp1 NAT 
and lower level of mRNA. This suggests that TgUlp1 NAT may play a role with managing 
the parasites stress response. Previous work in studied the relationship between bradyzoite 
and Ago and found that knockout of Argonaute expression resulted in an increase in 
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bradyzoite formation [73]. This suggests that RNAi and TgUlp1 NAT play a role in 
bradyzoite formation.  
RT-qPCR shows a drastic decrease in TgUlp1 mRNA level following stress and 
during bradyzoite life stage. Consequently, this would also affect TgUlp1 protein levels 
and ultimately the SUMOylation pathway in T. gondii. Previous work provides evidence 
that SUMOylation plays an important role in host cell invasion and cyst genesis [52]. If 
TgUlp1 NAT does regulate mRNA expression, it will provide more insight into the role of 
NAT in gene expression and pathogenesis in T. gondii. In addition, studies in other 
organisms provide evidence that NAT also exert their function in a trans-acting manner. 
Therefore, in addition to the cis-acting mechanism hypothesized and tested in this study, 
TgUlp1 NAT may also function in trans to regulate gene expression through various ways.  
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CONCLUSION 
NATs are widespread in eukaryotes and are being recognized as important 
regulators of gene expression. Although NATs are a common feature in Apicomplexan 
transcriptome, very little is known about their regulation, function, or its implications in 
cell biology. A NAT species was fortuitously discovered during the study of TgUlp1 
mRNA as a potential target of miR60 family. Studying the mechanisms controlling the 
function of TgUp1 NAT will provide more insight on the role NATs play in T. gondii. 
The objective of this study was to identify the elements controlling the expression 
of TgUlp1 NAT and elucidate its mechanism of function. Using a dual luciferase assay, we 
identified the promoter controlling the transcription of TgUlp1 mRNA and NAT. Although 
lacking a TATA box, the identified promoters contain many motifs that have been 
identified in T. gondii promoters as important for initiating transcription. Further work 
revealed that the promoters for TgUlp1 mRNA and NAT are active in tachyzoites but only 
NAT promoter is active in bradyzoites. RT-qPCR showed TgUlp1 mRNA was lower, but 
TgUlp1 NAT higher in bradyzoites compared to tachyzoites. Taken together, the data 
suggests that the expression of TgUlp1 NAT and mRNA are differentially regulated at the 
transcriptional level, via promoter activity and transcript turnover. Furthermore, this 
implies stage-specific expression of transcripts and therefore may provide insight on the 
role NATs have in tachyzoite-bradyzoite differentiation.  
TgUlp1 is the first gene confirmed as the target of miR60 family, which led us to 
hypothesize that TgUlp1 NAT is a regulatory RNA. Using a dual luciferase, we observed 
that when TgUlp1 NAT was in vitro processed by RNase III, the products retain the ability 
to lower the expression of engineered reporters carrying TgUlp1 mRNA sequences. This 
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suggests the involvement of RNAi. To further evaluate whether the Dicer and Argonaute, 
key enzymes in RNAi, are required for the processing and function of TgUlp1 NAT in vivo, 
RT-qPCR analysis was performed in TgDicer-KO and TgAgo-KO. We observed a lower 
level of TgUlp1 mRNA and higher level of TgUlp1 NAT in both strains compared to the 
parental. This indicates that Dicer and Ago are involved in maintaining TgUlp1 mRNA, 
We were unable to determine if in vitro TgUlp1 NAT had a direct affect on mRNA but did 
observe that electroporation alone caused decrease in mRNA and increase in NAT levels. 
The similar transcript levels between bradyzoites and mock electroporation suggest that 
TgUlp1 NAT may play a role in the parasite’s stress response. Consequently, these changes 
in TgUlp1 mRNA and NAT levels would also affect TgUlp1 protein levels and ultimately 
the SUMOylation pathway in T. gondii. Previous work in T. gondii show that 
SUMOylation plays an important role in host cell invasion and cyst genesis. If TgUlp1 
NAT does regulate mRNA expression, it would ultimately affect the parasites ability to 
invade and form cysts. Therefore, studying the role of TgUlp1 NAT plays in the parasite 
will provide more insight into the pathogenesis of T. gondii.   
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APPENDICES 
Appendix A 
 
 
 
 
Figure A1  pTUBRnLuc 
This diagram shows the plasmid coding for RnLuc under the control of TUB promoter. It 
was used as a positive control in dual luciferase assays for both identifying promoters and 
gene silencing. pTUBRnLuc was digested with NheI and HindIII to remove the tubulin 
(TUB) promoter (2717bps). The linearized product was ligated to putative promoter 
sequences that were amplified by PCR.  
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Figure A2 pRnLuc 
This diagram shows the plasmid coding for RnLuc without a promoter. It was used as a 
negative control for background expression in dual luciferase assays for identifying 
promoters.  
 
 
 
Figure A3  Diagram Showing Primers Used for TgUlp1 RT-qPCR. 
Schematic diagram of intron 6 to intron 8 from the TgUlp1 locus. Arrows indicate 
location of primer binding site. Green arrows are TgUlp1 mRNA primers and red arrows 
are TgUlp1 NAT primers used for RT-qPCR. Primer sequences are listed in Table B4.   
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Appendix B 
Table B1 Primers Used to Construct Plasmids For The Promoter Assay 
Digestion sites are highlighted in red  
Primer Name Sequence 
pr_RV_senseUlp1 (a) caccttggaagccatgctagcggccacacgagaggggaaaag 
pr_FW-senseUlp1 (b) gtcgacggtatcgataagcttctgcatcggtttgcgcct 
pr_FW-senseUlp1p1k (c) gtcgacggtatcgataagcttcaaccgagcggtgctggc 
pr_FW-senseUlp1p2.5k (d) gtcgacggtatcgataagcttagagcagaagagggagcc 
pr_RV_antisenUlp (e) caccttggaagccatgctagcgaccttcttcttcaacac 
pr_RV_antisenUlpAt1k (f) caccttggaagccatgctagcgaggtgagacaatggatc 
pr_FW-antisenUlp0.5k (g) gtcgacggtatcgataagcttgatccattgtctcacctc 
pr_FW-antisenUlp1k (h) gtcgacggtatcgataagcttcgtttgcagaactttcgc 
pr_FW-antisenUlp2k (i) gtcgacggtatcgataagcttgaggtcaaatgaccacgg 
 
Table B2 pPutPromRnLuc Used in the Promoter Assay 
Promoter Plasmid Name 
0.5-kb SS pRnpromoterUlp0.5k_SS 
1.0-kb SS pRnpromoterUlp1k_SS 
2.5-kb SS pRnpromoterUlp2.5k_SS 
0.5-kb AS pRnpromoterUlp0.5k_NAT 
1.0-kb AS pRnpromoterUlp1.0k_NAT 
2.5-kb AS pRnpromoterUlp2.5k_NAT 
2.0-kb AS pRnpromoterUlp2k_NAT 
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Table B3 Primers Used to Make Templates For in Vitro RNA 
T7 promoter sequence for in vitro transcription are highlighted in red  
Primer Name Sequence 
TgUlp1intron6Fw  ggctgaacgacgaagttatc 
TgUlp1intron7T7Rv taatacgactcactataggaacagaggcgaagtcgtaggt 
TgUlp1intron6T7Fw  taatacgactcactataggctgaacgacgaagttatc 
 
Table B4 Primers Used for RT-qPCR 
Primer Name Sequence 
RT_PCR Ulp1_Fw (j) cgtaacaagaagcaacgcgc 
RT_PCRUlp1_Rv (j') cgaacagaggcgaagtcgta 
qAntiUlp1Fw (k) tgggcgaagacggagaaga 
qAntiUlp1Rv (k') ttccaggtgaccgtaacatgtg 
qPCR_GAPDH_Fw ggtgttccgtgctgcgat 
qPCR_GAPDH_Rv gcctttccgccgacaat 
 
Table B5 Amount of Plasmid Electroporated Based on Experiment 
 Plasmid µg 
Establishing 
Promoter Assay 
pRnLuc 5 
p2.5kbSSRnLuc 5 
pTUBRnLuc 
5 
0.5 
0.05 
0.005 
0.0005 
In vitro NAT 
Electroporation 
pTUBRnLuc 5 
pTUBRnLuc_SiteA 5 
pTUBRnLuc_SiteB 5 
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Table B6 Initiator Element Identified in TgUlp1 Promoters  
Identified TgUlp1 sense and antisense promoter sequences were analyzed by ElemeNT for 
Initiator Element (Inr), YYANWYY, where Y = C/T, W = A/T, N = A/C/G/T. Only 
matches with PWM score >0.2 and complete consensus match are displayed.  
TgUlp1 
Promoter 
Sequence TgUlp1 Locus 
PWM 
Score 
1.0-kb 
mRNA 
Promoter 
5’ TGCCACTTCTCGTTGCGTTC 3’ 
3’ ACGGTGAAGAGCAACGCAAG 5’ 
5’-Flanking  
(-469 to -450) 
1.0000 
5’ GAGAGAAGTTGTCACATCTG 3’ 
3’ CTCTCTTCAACAGTGTAGAC 5’ 
5’-Flanking 
-1019 to -1000 
0.3636 
5’ GCTTTGTCACTTTTCCCCTC 3’ 
3’ CGAAACAGTGAAAAGGGGAG 5’ 
5’-Flanking 
-29 to -10 
 
0.4800 
2.0-kb NAT 
Promoter 
5’ TATGGGTCTGAGTCGCGCGT 3’ 
3’ ATACCCAGACTCAGCGCGCA 5’ 
Intron 9 
(+6051 to +6070) 
0.3410 
5’ CTCGGATTGAGTGCCTCGCG 3’ 
3’ GAGCCTAACTCACGGAGCGC 5’ 
Intron 10 
+6211 to +6230 
0.6499 
5’ TGTGGTTTGAAAGTCCCACT 3’ 
3’ ACACCAAACTTTCAGGGTGA 5’ 
Intron 10 
+6511 to +6530 
0.2954 
5’ CATTGAAGAGTGGTGCATCC 3’ 
3’ GTAACTTCTCACCACGTAGG 5’ 
Exon 11 
+6581 to +6600 
0.6000 
5’ GGGAAGTGAACAAGGACGGG 3’ 
3’ CCCTTCACTTGTTCCTGCCC 5’ 
Intron 11 
+6701 to +6720 
0.8000 
5’ GTGGGTGTGGAACCAGGTGT 3’ 
3’ CACCCACACCTTGGTCCACA 5’ 
Intron 11 
+6881 to +6900 
0.4545 
5’ GGAGAGTGACAAGCGAAGAG 3’ 
3’ CCTCTCACTGTTCGCTTCTC 5’ 
3’-Flanking 
+7441 to +7460 
0.4800 
5’ GAGAAAAAAGAATGAAGCAG 3’ 
3’ CTCTTTTTTCTTACTTCGTC 5’ 
3’-Flanking 
+7501 to +7520 
0.3600 
5’ ACGAAGTGACACGGGCCGGG 3’ 
3’ TGCTTCACTGTGCCCGGCCC 5’ 
3’-Flanking 
+7721 to +7740 
0.8000 
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Table B7 GAGACG  Motif Identified in TgUlp1 Promoters 
Sequence from identified TgUlp1 sense and antisense promoters were analyzed for 
GAGACG motif using Vector VNTI.  
TgUlp1 
Promoter 
Sequence TgUlp1 Locus 
1.0-kb 
mRNA 
Promoter 
5’ AAGCGTGGAGACGCAGAGAA 3’ 
3’ TTCGCACCTCTGCGTCTCTT 5’ 
3’-Flanking 
-229 to -210 
2.0-kb NAT 
Promoter 
5’ AGTCGCGCGTCTCGGTTCTC 3’  
5’ TCAGCGCGCAGAGCCAAGAG 3’ 
 
5’ GATCGTGTGCGTCTCGAGCG 3’  
5’ CTAGCACACGCAGAGCTCGC 5’  
 
5’ TTTCGCGTCTCTTCGGTGAT 3’ 
3’ AAAGCGCAGAGAAGCCACTA 5’ 
 
5’ CTTTTGCTCGCGTCTCCGGA 3’ 
3’ GAAAACGAGCGCAGAGGCCT 5’ 
Intron 9 
+6061 to +6080 
 
Intron 10 
+6421 to +6440 
 
Intron 10 
+6451 t + 6470 
 
3’-Flanking 
+7641 to +7660 
 
Table B8 TGCATGC Motif Identified in TgUlp1 Promoters 
Sequence from identified TgUlp1 sense and antisense promoters were analyzed for 
TGCATGC motif using Vector VNTI. 
TgUlp1 
Promoter 
Sequence TgUlp1 Locus 
1.0-kb 
mRNA 
Promoter 
N/A N/A 
2.0-kb NAT 
Promoter 
5’ TCTCTGCATGCATATCGCTC 3’ 
3’ AGAGACGTACGTATAGCGAG 5’ 
 
5’ GGGAAGCATGCACAGAGAAG 3’ 
3’ CCCTTCGTACGTGTCTCTTC 5’ 
 
5’ GCTTCCGCGCATGCAGGCTC 3’ 
3’ CGAAGGCGCGTACGTCCGAG 5’ 
Intron 9 
+6011 to + 6030 
 
Intron 10 
+6281 to +6300 
 
Exon 13 
+7381 to + 7400 
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